Unknown

Dataset Information

0

Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential.


ABSTRACT: AML1-ETO (RUNX1-ETO) fusion proteins are generated by the 8;21 translocation, commonly found in acute myeloid leukemia, which fuses the AML1 (RUNX1) and ETO (MTG8, RUNX1T1) genes. Previous studies have shown that AML1-ETO interferes with AML1 function but requires additional cooperating mutations to induce leukemia development. In mouse models, AML1-ETO forms lacking the C-terminus have been shown to have greatly enhanced leukemogenic potential. Here, we investigate the role of 2 AML1-ETO C-terminal-interacting proteins, N-CoR, a transcriptional corepressor, and SON, a splicing/transcription factor required for cell cycle progression, in AML1-ETO-induced leukemia development. AML1-ETO-W692A loses N-CoR binding at NHR4, displays attenuated transcriptional repression ability and decreased cellular dysregulation, and promotes leukemia in vivo. These results support the importance of the degree of dysregulation by AML1-ETO in cellular transformation and demonstrate that AML1-ETO-W692A can be used as an effective experimental model for determining which factors compromise the leukemogenic potential of AML1-ETO.

SUBMITTER: DeKelver RC 

PROVIDER: S-EPMC3643768 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential.

DeKelver Russell C RC   Yan Ming M   Ahn Eun-Young EY   Shia Wei-Jong WJ   Speck Nancy A NA   Zhang Dong-Er DE  

Blood 20130220 18


AML1-ETO (RUNX1-ETO) fusion proteins are generated by the 8;21 translocation, commonly found in acute myeloid leukemia, which fuses the AML1 (RUNX1) and ETO (MTG8, RUNX1T1) genes. Previous studies have shown that AML1-ETO interferes with AML1 function but requires additional cooperating mutations to induce leukemia development. In mouse models, AML1-ETO forms lacking the C-terminus have been shown to have greatly enhanced leukemogenic potential. Here, we investigate the role of 2 AML1-ETO C-term  ...[more]

Similar Datasets

| S-EPMC2423149 | biostudies-literature
| S-EPMC5336278 | biostudies-literature
| S-EPMC2945414 | biostudies-literature
| S-EPMC2668852 | biostudies-literature
| S-EPMC2699238 | biostudies-literature
| S-EPMC2234055 | biostudies-literature
| S-EPMC3367897 | biostudies-literature
| S-EPMC2577924 | biostudies-literature
| S-EPMC6820555 | biostudies-literature
| S-EPMC2630273 | biostudies-literature